1. Bristol-Myers gets breakthrough status for Opdivo-Yervoy combo in liver cancer — Roche SMA trial of risdiplam hits target— AbbVie submits sNDA for Imbruvica/Rituximab combo for CLL — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Ulthera

Anonymous board for Ulthera


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    3
    Views:
    2,570
  2. Anonymous
    Replies:
    5
    Views:
    7,776
  3. Anonymous
    Replies:
    1
    Views:
    3,185

Thread Display Options

Loading...